http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-10123587-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 |
filingDate | 2001-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b9d05fb4b598852a9b310752f43a5fe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0978221c5ec1ad380ebc424b85469c82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b29042e398c3edaaac18f0274fc190d8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3203dd25c3d8e088302bdf1a4490911 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f85180101001463316342cf1b51693b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c02c5acdf8352ac2f8f442837699dfa0 |
publicationDate | 2002-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | DE-10123587-A1 |
titleOfInvention | Cyanoanthranylamide derivatives and their use as medicines |
abstract | Substituted cyanoanthranylamide, its production and use as a medicament for the treatment of diseases caused by persistent angiogenesis are described. The compounds of the invention can be used as or in psoriasis, Kaposis sarcoma, restenosis, such as. B. Stent-induced restenosis, endometriosis, Crohn's disease, Hodgkins disease, leukemia, arthritis, such as rheumatoid arthritis, hemangioma, angiofribroma, eye diseases, such as diabetic retinopathy, neovascular glaucoma, kidney diseases, such as glomerulonephritis, diabetic malignant nephropathy, diabetic malignant nephropathy, malignant nephropathy, diabetic malignant nephropathy, diabetic malignant nephropathy, diabetic malignant nephropathy, diabetic malignant nephropathy, diabetic malignant nephropathy, malignant nephropathy, diabetic malignant nephropathy, diabetic malignant nephropathy, diabetic malignant nephropathy , Transplant rejection and glomerulopathy, fibrotic diseases such as cirrhosis of the liver, mesangial cell proliferative diseases, atherosclerosis, injuries to the nervous tissue and inhibition of reocclusion of vessels after balloon catheter treatment, in vascular prosthetics moderately after the use of mechanical devices for keeping vessels open, such as, for. B. stents, as immunosuppressants, as support for scar-free wound healing, age spots and contact dermatitis. |
priorityDate | 2001-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 391.